Foghorn Therapeutics Inc. (FHTX) Interest Expense USD 2019 - 2022

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Foghorn Therapeutics Inc. quarterly/annual Interest Expense history and growth rate from 2019 to 2022.
  • Foghorn Therapeutics Inc. Interest Expense for the quarter ending September 30, 2022 was $0.000, a 100% decline year-over-year.
  • Foghorn Therapeutics Inc. Interest Expense for the twelve months ending September 30, 2022 was $426 K, a 76.3% decline year-over-year.
  • Foghorn Therapeutics Inc. annual Interest Expense for 2021 was $1.91 M, a 94.7% increase from 2020.
  • Foghorn Therapeutics Inc. annual Interest Expense for 2020 was $979 K, a 81.3% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $426 K $0 -$499 K -100% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $925 K $0 -$495 K -100% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $1.42 M $0 -$486 K -100% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $1.91 M $426 K +$105 K +32.7% Oct 1, 2021 Dec 31, 2021 10-K/A 2022-08-09
Q3 2021 $1.8 M $499 K +$297 K +147% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $1.5 M $495 K +$297 K +150% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $1.21 M $486 K +$228 K +88.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $979 K $321 K Oct 1, 2020 Dec 31, 2020 10-K/A 2022-08-09
Q3 2020 $202 K +$89 K +78.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $198 K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $258 K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $113 K Jul 1, 2019 Sep 30, 2019 10-Q 2020-12-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.